U
Jade Biosciences, Inc. JBIO
$7.33 -$0.07-0.95% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025
Total Cash And Short-Term Investments 49.93M
Total Receivables --
Inventory --
Prepaid Expenses 775.00K
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets 50.70M

Total Current Assets 50.70M
Net Property, Plant & Equipment 765.00K
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets 4.86M
Total Assets 56.32M

Total Accounts Payable 4.22M
Total Accrued Expenses 9.79M
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities 2.04M
Total Other Current Liabilities 2.04M
Total Current Liabilities 16.05M

Total Current Liabilities 16.05M
Long-Term Debt 123.00M
Short-term Debt --
Capital Leases 783.00K
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities 139.83M

Common Stock & APIC 1.64M
Retained Earnings -85.15M
Treasury Stock & Other --
Total Common Equity -83.51M

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible 2.00K
Preferred Stock, Others --
Total Preferred Equity 2.00K

Total Common Equity -83.51M
Total Preferred Equity 2.00K
Total Minority Interest --
Total Equity -83.51M